¼¶±ð: Ôº³¤
UID: 86215
¾«»ª: 0
·¢Ìû: 972
ÍþÍû: 15 µã
»ý·Öת»»
ÓÞÓÞ±Ò: 1182 YYB
ÔÚÏß³äÖµ
¹±Ï×Öµ: 0 µã
ÔÚÏßʱ¼ä: 260(Сʱ)
×¢²áʱ¼ä: 2010-02-22
×îºóµÇ¼: 2022-08-22
Â¥Ö÷  ·¢±íÓÚ: 2018-09-17 10:58

 ¼ä³äÖʸÉϸ°ûͨ¹ýÒÖÖÆСÊóÖÐTollÑùÊÜÌå-4µÄ»îÐÔÀ´¸ÄÉÆСÊóÂýÐԽ᳦Ñ×Ö¢

±³¾°

    Ä¿Ç°ÒÑÖª¶àÖÖ³¦Íâ±íÏÖ(EIM)°üÀ¨¸Îµ¨²¢·¢Ö¢£¬¶¼ÓëÓëÑ×ÐÔ³¦²¡(IBD)Óйء£Ò²Óб¨µÀÏÔʾ¼ä³äÖʸÉϸ°û(MSC)ÒÆÖ²ÔÚIBDµÄÖÎÁÆÖз¢»ÓÓÐDZÔÚµÄÁÆЧ¡£Òò´Ë£¬±¾Ñо¿Ö¼ÔÚ̽ÌÖ¼ä³äÖʸÉϸ°û(MSC)ÔÚʹÓÃÁòËáÆϾÛÌÇÄÆ(DSS)ÓÕµ¼µÄСÊóÂýÐԽ᳦Ñ×Ä£Ð͵ĸÄÉÆ×÷Óá£

    ·½·¨

    Ñо¿ÈËÔ±ÏȽ¨Á¢DSSÓÕµ¼µÄСÊóÂýÐԽ᳦Ñ×Ä£ÐÍ£¬²¢ÓÃMSCÖÎÁÆ¡£²ÉÓü²²¡»î¶¯Ö¸Êý(DAI)£¬ÌåÖØ(BW)£¬½á³¦³¤¶ÈºÍ×éÖ¯²¡ÀíѧÀ´ÆÀ¹À½á³¦Ñ×µÄÑÏÖس̶ȡ£Í¨¹ýϸ°ûÁѽâÎï²âÊÔ(LAL-²âÊÔ)¼ì²âѪÇåÖ¬¶àÌÇ(LPS)ˮƽ¡£Í¬Ê±¶ÔСÊóµÄ×é֯ѧºÍ¸Î¹¦ÄܽøÐÐÏà¹Ø¼ì²â¡£Ñо¿ÈËԱͬʱ¶ÔѪÇåLPSˮƽºÍ³¦ÏµÄ¤Áܰͽá(MLN)µÄϸ¾úÒÆλ½øÐÐÁË·ÖÎö¡£±¾ÏîÑо¿Öж¨ÒåµÄ´ÙÑ×ϸ°ûÒò×Ó°üÀ¨Ö×Áö»µËÀÒò×Ó-α(TNF-α)£¬¸ÉÈÅËØ-γ(IFN-γ)£¬°×ϸ°û½éËØ-1β(IL-1β)£¬°×ϸ°û½éËØ-17A(IL-17A)£¬TollÊÜÌå4(TLR4)£¬²¢·Ö±ðÓ*************************âÒß×黯Ⱦɫ£¬ÃâÒßÓ¡¼£·ÖÎöºÍʵʱӫ¹â¶¨Á¿PCR¼ì²âTNFÊÜÌåÏà¹ØÒò×Ó6(TRAF6)ºÍºËÒò×ÓκB(NF-κB)µÄŨ¶È¡£

    ½á¹û

    DSSÓÕµ¼µÄÂýÐԽ᳦Ñ×СÊóÄ£Ð͵ÄÌØÕ÷±íÏÖÔÚÓÚBW¼õÉÙ£¬DAIÉý¸ß£¬×é֯ѧÑ×Ö¢¶ñ»¯£¬ÒÔ¼°¸ßˮƽµÄLPSºÍ´ó³¦¸Ë¾úÒ×λ¡£DSS¸øÒ©ºóÑо¿ÈËÔ±¹Û²ìµ½Ð¡Êó¸ÎÔà×éÖ¯³öÏÖ²¡ÀíѧËðÉË£¬¸Î¹¦ÄÜÊÜË𣬵°°×ÖʺÍTNF-ᣬIFN-㣬IL-1⣬IL-17A£¬TLR4£¬TRAF6ºÍNF-κBµÄmRNAˮƽÉý¸ß¡£¶ÔСÊó½øÐÐMSCsÒÆÖ²ºó£¬MSCsͨ¹ý½µµÍLPSˮƽ£¬½µµÍTNF-ᣬIFN-㣬IL-1⣬IL-17A£¬TLR4£¬TRAF6ºÍNF-κBµÄµ°°×ºÍmRNA±í´ï£¬ÏÔןÄÉÆÁ˽᳦ºÍ¸ÎÔàµÄ²¡ÀíµÄ±íÏÖ¡£

    ½áÂÛ

    MSCs¿Éͨ¹ýLPS / TLR4;¾¶ÒÖÖƳ¦Ô´ÐÔÄÚ¶¾ËØѪ֢ºÍ¸ÎÔàÑ×Ö¢£¬¸ÄÉÆÂýÐԽ᳦Ñ×Ïà¹Ø¸Îµ¨²¢·¢Ö¢¡£MSCs½«À´¿ÉÄÜ»á³ÉΪÂýÐԽ᳦Ñ×Ïà¹Ø¸Îµ¨²¢·¢Ö¢µÄÐÂÐÍÖÎÁÆ·½·¨¡£

    Ô­Ê¼³ö´¦£º

    Guo chao Niu. Et al.Mesenchymal stem cell transplantation improves Chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.BMC Gastroenterology.2018.
·ÖÏí:

ÓÞÓÞѧ԰ÊôÓÚ´¿Ñ§Êõ¡¢·Ç¾­ÓªÐÔרҵÍøÕ¾£¬ÎÞÈκÎÉÌÒµÐÔÖÊ£¬´ó¼Ò³öÓÚѧϰºÍ¿ÆÑÐÄ¿µÄ½øÐн»Á÷ÌÖÂÛ¡£

ÈçÓÐÉæÇÖ·¸Öø×÷ȨÈ˵İæȨµÈÐÅÏ¢£¬Ç뼰ʱÀ´ÐŸæÖª£¬ÎÒÃǽ«Á¢¿Ì´ÓÍøÕ¾ÉÏɾ³ý£¬²¢ÏòËùÓгְæȨÕßÖÂ×îÉîǸÒ⣬лл¡£